MJHLS - Medical Communications Fellowship
Listed on 2026-01-27
-
Healthcare
Healthcare Administration, Medical Education
Overview
2 position(s) for Medical Communications
Fellowship Position Office
Location:
Monroe Township, NJ 08831, HYBRID
POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, has over 40 years of expertise in offering innovative Post-Doctoral Pharm.
D. Fellowships that provide extensive training in the pharmaceutical and biopharmaceutical industry. This 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships (RPIF) and MJH Life Sciences
. Program emphasis is in Medical Communications
. This 2-year Fellowship provides a unique opportunity to partake in four 6-month rotations throughout MJH Life Sciences, providing medical communication in various formats. The first three rotations are standardized to allow the fellow time with the Clinical Communications:
Oncology, Clinical Communications:
Multispecialty and Pharmacy Times Continuing Education (PTCE) teams. The fellow will choose the fourth rotation based on their interests and preferences. The Fellow will gain experience with leadership and management, content strategy and delivery, professional communication, and presentations. As part of the Clinical Communications Oncology and Multispecialty teams, the fellow will aid in producing content for publications, video programming, and live/virtual meetings for patients, physicians, pharmacists, and other healthcare professionals.
With the PTCE team, the fellow will participate in creating continuing pharmacy education (CPE) activities for pharmacists in various settings via print, online, and digital activities, as well as live satellite symposia and conferences.
University-based experiences complement the industry experiences and include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.
D.’s in the pharmaceutical and biopharmaceutical industry and help fuel your career as a future leader. For more information and to apply, please visit the Rutgers Pharma Fellows website. (The original link was removed for formatting compliance.)
Do not click the “Apply Now” button to the right. We do not accept applications or schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at the Rutgers Pharma Fellows site.
The RPIF Program application portal opens at 12 PM ET on October 8th. Initial interviews will be conducted on a rolling basis virtually (video conference) starting October 20th. To apply, candidates MUST use the RPIF website to create a RPIF Candidate Account and upload the required application materials by the dates noted below. Remember that the application process is on a rolling basis, so earlier is better.
Please see the Rutgers site for additional important recruitment information and dates.
Initial offers will not be made until December 12th, the AIFA (Alliance of Industry Fellowship Associates) consensus date for first offers. Once all interviews have been completed, RPIF or the company will notify interviewed candidates of their position-specific candidacy status.
Application ProcessCandidate Checklist:
- Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Complete the brief RPIF portal short-answer questions and you should upload your Letter of Intent and CV by October 17th, 2025.
- Begin securing letters of recommendation because all 3 must be received before you can be fully considered for an offer. All 3 letters of recommendation should be submitted by December 1st, 2025.
As a University, Rutgers recognizes that the diversity of its…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).